Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

OPC-14117: tolerability and safety as antioxidant therapy for Huntington's disease

July 7, 1998

S-8510 enhances cognition and acetylcholine release in basal forebrain-lesioned rats

July 6, 1998

CNI-1493 treatment associated with improvement in mouse model of MS

July 6, 1998

Nihon Nohyaku claims arylpiperidines for schizophrenia, dementia

July 6, 1998

Berlex and Chiron file with FDA to treat progressive form of MS

July 6, 1998

Analgesics prepared at Ostuka

July 3, 1998

Taisho claims antipsychotic agents devoid of extrapyramidal side effects

July 3, 1998

COX-2 inhibitors for GBS and CIDP

July 3, 1998

EPC-K1 inhibits striatal dopamine release in rat model of ischemia

July 2, 1998

Combination of MS-818 and bFGF enhances neuronal activity

July 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...